[Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
D002614:Chelating Agents / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D002952:Citric Acid Cycle; D003094:Collagen / Q000378:metabolism; D003300:Copper / Q000378:metabolism; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D006909:Hydroxyproline / Q000378:metabolism; D007842:Lathyrism / Q000139:chemically induced*; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013997:Time Factors
D002614:Chelating Agents; D003300:Copper; D003094:Collagen; D010396:Penicillamine; D006909:Hydroxyproline
Penicylamina w leczeniu twardziny. Leki o działaniu latyrogennym.